From: Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series
 |  | choriocarcinoma arising from mole (n = 9) | Choriocarcinoma from biparental pregnancy (n = 5) | non-gestational choriocarcinoma (n = 1) |
---|---|---|---|---|
Surgery (n, %) | Hysterectomy | 2 (22%) | 2 (40%) | 0 |
Uterine curetting | 5 (56%) | 2 (40%) | 0 | |
Pelvic mass resection | 1 (11%) | 0 | 1 (100%) | |
Adnexectomy | 1 (11%) | 1 (420%) | 1 (100%) | |
Prognosis(n) | Alive, no evidence of disease | 9 | 5 | Â |
Lost of follow-up | Â | Â | 1 | |
Chemotherapy (n, %) | First-line single-agent alone | 3 (33.3%) | 0 | 0 |
First-line multi-agent alone | 4 (44.4%) | 2 (40%) | 1 (100%) | |
Salvage multi-agent chemotherapy | 2 (22.2%) | 3 (60%) | 0 |